Ubon Bio Ethanol PCL (BKK:UBE)
Thailand · Delayed Price · Currency is THB 0.5700
+0.0300 (5.56%)
May 22, 2026, 4:36 PM ICT
Ubon Bio Ethanol PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 4,916 | 5,193 | 6,466 | 5,838 | 7,199 | 6,972 |
Other Revenue | 0.1 | - | - | - | - | - |
| 4,916 | 5,193 | 6,466 | 5,838 | 7,199 | 6,972 | |
Revenue Growth (YoY) | -18.29% | -19.69% | 10.75% | -18.91% | 3.25% | 57.23% |
Cost of Revenue | 4,424 | 4,641 | 5,585 | 5,316 | 6,298 | 5,931 |
Gross Profit | 491.7 | 551.4 | 880.02 | 521.82 | 901.7 | 1,041 |
Selling, General & Admin | 546.38 | 548.08 | 539.5 | 450.31 | 503 | 560.96 |
Other Operating Expenses | 29.34 | 24.54 | 57.79 | 145.88 | 37.8 | -25.61 |
Operating Expenses | 575.73 | 572.63 | 597.29 | 596.19 | 540.8 | 535.35 |
Operating Income | -84.03 | -21.23 | 282.73 | -74.36 | 360.9 | 506.11 |
Interest Expense | -21.93 | -29.33 | -54.75 | -49.06 | -49.99 | -129.07 |
Earnings From Equity Investments | -2.08 | -0.18 | - | - | - | - |
Currency Exchange Gain (Loss) | - | - | - | - | -52.48 | -52.77 |
Other Non Operating Income (Expenses) | 11.77 | 16.37 | -8.75 | -10.86 | -2.34 | -3.4 |
EBT Excluding Unusual Items | -96.26 | -34.36 | 219.24 | -134.29 | 256.09 | 320.88 |
Pretax Income | -96.26 | -34.36 | 219.24 | -134.29 | 256.09 | 320.88 |
Income Tax Expense | 65.18 | 44.78 | -34.73 | -37.71 | -73.12 | - |
Earnings From Continuing Operations | -161.44 | -79.14 | 253.97 | -96.57 | 329.21 | 320.88 |
Minority Interest in Earnings | -22.44 | -23.94 | -1.46 | - | - | - |
Net Income | -183.89 | -103.09 | 252.51 | -96.57 | 329.21 | 320.88 |
Net Income to Common | -183.89 | -103.09 | 252.51 | -96.57 | 329.21 | 320.88 |
Net Income Growth | - | - | - | - | 2.60% | 223.04% |
Shares Outstanding (Basic) | 3,914 | 3,914 | 3,914 | 3,914 | 3,914 | 3,046 |
Shares Outstanding (Diluted) | 3,914 | 3,914 | 3,914 | 3,914 | 3,914 | 3,046 |
Shares Change (YoY) | - | - | - | - | 28.49% | 11.19% |
EPS (Basic) | -0.05 | -0.03 | 0.06 | -0.02 | 0.08 | 0.11 |
EPS (Diluted) | -0.05 | -0.03 | 0.06 | -0.02 | 0.08 | 0.11 |
EPS Growth | - | - | - | - | -20.15% | 190.54% |
Free Cash Flow | - | 1,102 | 857.1 | 65.44 | 224.48 | 690.99 |
Free Cash Flow Per Share | - | 0.28 | 0.22 | 0.02 | 0.06 | 0.23 |
Dividend Per Share | 0.015 | 0.015 | 0.024 | 0.016 | 0.040 | 0.024 |
Dividend Growth | -35.17% | -35.17% | 51.28% | -61.00% | 67.36% | -40.40% |
Gross Margin | 10.00% | 10.62% | 13.61% | 8.94% | 12.53% | 14.94% |
Operating Margin | -1.71% | -0.41% | 4.37% | -1.27% | 5.01% | 7.26% |
Profit Margin | -3.74% | -1.98% | 3.91% | -1.65% | 4.57% | 4.60% |
Free Cash Flow Margin | - | 21.22% | 13.26% | 1.12% | 3.12% | 9.91% |
EBITDA | 309.15 | 368.71 | 659.23 | 302.77 | 749.68 | 881.14 |
EBITDA Margin | 6.29% | 7.10% | 10.20% | 5.19% | 10.41% | 12.64% |
D&A For EBITDA | 393.18 | 389.94 | 376.5 | 377.14 | 388.77 | 375.03 |
EBIT | -84.03 | -21.23 | 282.73 | -74.36 | 360.9 | 506.11 |
EBIT Margin | -1.71% | -0.41% | 4.37% | -1.27% | 5.01% | 7.26% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.